HeartFlow’s AI-enabled plaque quantification technology has been upgraded to a new I CPT category code by the American Medical Association.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

Continuous moderate-level maternal psychological distress throughout pregnancy is associated with a heightened risk for epilepsy among offspring.

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

A large study suggests that, across the most populous US states, few physicians are disciplined for spreading medical ...

Diabetic hypoglycemia occurs when a person's blood sugar level falls too low. Symptoms can include: shakiness, confusion or ...

Detailed results were announced from the phase 3 SUMMIT trial evaluating the use of tirzepatide in adults with HFpEF and obesity.

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

An age-equivalent benefit is found for vigorous exercise, after considering sitting time, according to a study recently published.

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation (OC) have complications.

GLP-1RA medications in preadolescents and adolescents were concentrated among those with diabetes, obesity, mood disorders, and anxiety.